Close

Protalix Bio (PLX) Gets Elelyso Marketing Authorization in Israel

September 27, 2012 6:33 AM EDT Send to a Friend
Protalix BioTherapeutics, Inc. (AMEX: PLX) has received marketing authorization from the Israeli Ministry of Health for Elelyso (taliglucerase alfa) for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login